Shelton Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.12M | Hold |
182,411
| – | – | 0.11% | 145 |
|
|
2025
Q4 | $4.54M | Sell |
182,411
-523
| -0.3% | -$13.2K | 0.09% | 169 |
|
|
2025
Q3 | $4.66M | Sell |
182,934
-543
| -0.3% | -$13.4K | 0.1% | 160 |
|
|
2025
Q2 | $4.45M | Buy |
183,477
+4,951
| +3% | +$115K | 0.1% | 174 |
|
|
2025
Q1 | $4.52M | Buy |
178,526
+11,342
| +7% | +$297K | 0.11% | 159 |
|
|
2024
Q4 | $4.44M | Sell |
167,184
-1,098
| -0.7% | -$29.8K | 0.11% | 166 |
|
|
2024
Q3 | $4.87M | Sell |
168,282
-5,368
| -3% | -$157K | 0.13% | 152 |
|
|
2024
Q2 | $4.86M | Sell |
173,650
-59,803
| -26% | -$1.65M | 0.13% | 150 |
|
|
2024
Q1 | $6.48M | Sell |
233,453
-102,790
| -31% | -$2.85M | 0.18% | 128 |
|
|
2023
Q4 | $9.68M | Sell |
336,243
-11,919
| -3% | -$360K | 0.31% | 74 |
|
|
2023
Q3 | $11.5M | Sell |
348,162
-6,290
| -2% | -$222K | 0.42% | 47 |
|
|
2023
Q2 | $13M | Buy |
354,452
+6,912
| +2% | +$269K | 0.47% | 43 |
|
|
2023
Q1 | $14.2M | Buy |
347,540
+198,540
| +133% | +$8.58M | 0.59% | 28 |
|
|
2022
Q4 | $7.63M | Sell |
149,000
-2,469
| -2% | -$118K | 0.8% | 18 |
|
|
2022
Q3 | $6.63M | Sell |
151,469
-1,312
| -0.9% | -$63.8K | 0.32% | 82 |
|
|
2022
Q2 | $8.01M | Buy |
152,781
+34,792
| +29% | +$1.77M | 0.36% | 72 |
|
|
2022
Q1 | $6.11M | Buy |
117,989
+71,331
| +153% | +$3.7M | 0.23% | 98 |
|
|
2021
Q4 | $2.75M | Buy |
46,658
+805
| +2% | +$39.9K | 0.1% | 209 |
|
|
2021
Q3 | $1.97M | Sell |
45,853
-295
| -0.6% | -$13.1K | 0.08% | 228 |
|
|
2021
Q2 | $1.81M | Sell |
46,148
-164,636
| -78% | -$6.4M | 0.07% | 235 |
|
|
2021
Q1 | $7.64M | Buy |
210,784
+103,196
| +96% | +$3.66M | 0.27% | 82 |
|
|
2020
Q4 | $3.96M | Sell |
107,588
-5,995
| -5% | -$220K | 0.18% | 120 |
|
|
2020
Q3 | $3.96M | Sell |
113,583
-527
| -0.5% | -$18.5K | 0.16% | 141 |
|
|
2020
Q2 | $3.54M | Buy |
114,110
+20,342
| +22% | +$691K | 0.2% | 105 |
|
|
2020
Q1 | $2.9M | Sell |
93,768
-8,072
| -8% | -$275K | 0.21% | 96 |
|
|
2019
Q4 | $3.79M | Sell |
101,840
-158,537
| -61% | -$5.65M | 0.21% | 98 |
|
|
2019
Q3 | $8.88M | Sell |
260,377
-4,111
| -2% | -$149K | 0.52% | 45 |
|
|
2019
Q2 | $10.9M | Buy |
264,488
+254,762
| +2,619% | +$10.1M | 0.63% | 33 |
|
|
2019
Q1 | $217K | Sell |
9,726
-193,776
| -95% | -$7.76M | 0.86% | 16 |
|
|
2018
Q4 | $8.43M | Sell |
203,502
-28,564
| -12% | -$1.19M | 0.57% | 39 |
|
|
2018
Q3 | $9.7M | Buy |
232,066
+163,100
| +236% | +$6.28M | 0.55% | 41 |
|
|
2018
Q2 | $2.37M | Buy |
68,966
+2,835
| +4% | +$96.9K | 0.15% | 138 |
|
|
2018
Q1 | $2.23M | Sell |
66,131
-4,437
| -6% | -$153K | 0.15% | 138 |
|
|
2017
Q4 | $2.42M | Sell |
70,568
-5,679
| -7% | -$194K | 0.16% | 132 |
|
|
2017
Q3 | $2.58M | Sell |
76,247
-94,516
| -55% | -$3.04M | 0.17% | 127 |
|
|
2017
Q2 | $5.44M | Sell |
170,763
-28,354
| -14% | -$894K | 0.38% | 57 |
|
|
2017
Q1 | $6.46M | Buy |
199,117
+32,642
| +20% | +$1.03M | 0.45% | 40 |
|
|
2016
Q4 | $5.13M | Buy |
166,475
+52,115
| +46% | +$1.59M | 0.39% | 46 |
|
|
2016
Q3 | $3.67M | Buy |
114,360
+36,850
| +48% | +$1.23M | 0.31% | 65 |
|
|
2016
Q2 | $2.59M | Sell |
77,510
-4,586
| -6% | -$146K | 0.23% | 84 |
|
|
2016
Q1 | $2.31M | Buy |
82,096
+7,276
| +10% | +$208K | 0.21% | 93 |
|
|
2015
Q4 | $2.29M | Buy |
74,820
+13,050
| +21% | +$411K | 0.22% | 95 |
|
|
2015
Q3 | $1.84M | Buy |
61,770
+5,826
| +10% | +$187K | 0.2% | 102 |
|
|
2015
Q2 | $1.78M | Sell |
55,944
-3,313
| -6% | -$108K | 0.18% | 110 |
|
|
2015
Q1 | $1.96M | Buy |
59,257
+488
| +0.8% | +$15.5K | 0.21% | 101 |
|
|
2014
Q4 | $1.74M | Sell |
58,769
-13,491
| -19% | -$387K | 0.2% | 103 |
|
|
2014
Q3 | $2.03M | Buy |
72,260
+13,305
| +23% | +$373K | 0.27% | 81 |
|
|
2014
Q2 | $1.66M | Sell |
58,955
-527
| -0.9% | -$15K | 0.23% | 89 |
|
|
2014
Q1 | $1.81M | Buy |
59,482
+1,897
| +3% | +$56.6K | 0.27% | 82 |
|
|
2013
Q4 | $1.67M | Sell |
57,585
-6,219
| -10% | -$181K | 0.25% | 84 |
|
|
2013
Q3 | $1.74M | Sell |
63,804
-2,134
| -3% | -$58.1K | 0.29% | 74 |
|
|
2013
Q2 | $1.75M | Buy |
+65,938
| New | +$1.82M | 0.32% | 74 |
|
Other funds holding PFE
VCM
VPM
Shelton Capital Management's PFE Position: Q1 2026 in Review
Shelton Capital Management held its Pfizer (PFE) position steady in Q1 2026 at 182,411 shares worth $5.12M. The position accounts for 0.11% of the portfolio, ranked #145.
Shelton Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.2M in Q1 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Shelton Capital Management held 182,411 shares of Pfizer worth $5.12M as of Q1 2026.
- Shelton Capital Management left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 0.11% of Shelton Capital Management's portfolio in Q1 2026, its #145 holding.
- Shelton Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Shelton Capital Management's Pfizer position peaked at $14.2M in Q1 2023.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Shelton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.